Artemyrianosins A–J, cytotoxic germacrane-type sesquiterpene lactones from Artemisia myriantha

doi:10.1007/s13659-022-00340-5

Natural Products and Bioprospecting ›› 2022, Vol. 12 ›› Issue (3): 16-16.DOI: 10.1007/s13659-022-00340-5

• ORIGINAL ARTICLES • Previous Articles Next Articles

Artemyrianosins A–J, cytotoxic germacrane-type sesquiterpene lactones from Artemisia myriantha

Xin Zhang^1,2, Yun-Bao Ma¹, Xiao-Feng He¹, Tian-Ze Li¹, Chang-An Geng¹, Li-Hua Su¹, Shuang Tang¹, Zhen Gao^1,2, Ji-Jun Chen^1,2

1 State Key Laboratory of Phytochemistry and Plant Resources in West China, Yunnan Key Laboratory of Natural Medicinal Chemistry, Kunming Institute of Botany, Chinese Academy of Sciences, 132# Lanhei Road, Kunming, 650201, Yunnan, People's Republic of China;
2 University of Chinese Academy of Sciences, Beijing, 100049, People's Republic of China

Received:2022-03-04 Online:2022-06-24 Published:2022-06-24
Contact: Ji-Jun Chen,E-mail:chenjj@mail.kib.ac.cn
Supported by:
This work was supported by the Key Program of the National Natural Science Foundation of China (22137008) and the Yunnan Wanren Project (YNWR-KJLJ-2019-002).

Artemyrianosins A–J, cytotoxic germacrane-type sesquiterpene lactones from Artemisia myriantha

Xin Zhang^1,2, Yun-Bao Ma¹, Xiao-Feng He¹, Tian-Ze Li¹, Chang-An Geng¹, Li-Hua Su¹, Shuang Tang¹, Zhen Gao^1,2, Ji-Jun Chen^1,2

1 State Key Laboratory of Phytochemistry and Plant Resources in West China, Yunnan Key Laboratory of Natural Medicinal Chemistry, Kunming Institute of Botany, Chinese Academy of Sciences, 132# Lanhei Road, Kunming, 650201, Yunnan, People's Republic of China;
2 University of Chinese Academy of Sciences, Beijing, 100049, People's Republic of China

通讯作者: Ji-Jun Chen,E-mail:chenjj@mail.kib.ac.cn
基金资助:
This work was supported by the Key Program of the National Natural Science Foundation of China (22137008) and the Yunnan Wanren Project (YNWR-KJLJ-2019-002).

Abstract

Abstract: Ten new germacrane-type sesquiterpenoids, artemyrianosins A–J (1–10), were isolated from the aerial parts of Artemisia myriantha. Their structures were elucidated by spectral analyses including UV, IR, HRESIMS, 1D and 2D NMR, ECD and the absolute configurations of compounds 1 and 7–9 were characterized using X-ray crystallography. All isolates were tested their cytotoxicity against three human hepatoma cell lines (HepG2, Huh7, and SK-Hep-1), and compounds 1–3, 7, and 10 showed cytotoxicity with IC₅₀ values ranging from 43.7 to 89.3 μM. Among them, the most active compound 3 exhibited activity against three human hepatoma cell lines with IC₅₀ values of 43.7 μM (HepG2), 47.9 μM (Huh7), and 44.9 μM (SK-Hep-1).

Key words: Artemisia myriantha, Artemyrianosins A–J, Germacrane-type sesquiterpenoids, Cytotoxicity

摘要： Ten new germacrane-type sesquiterpenoids, artemyrianosins A–J (1–10), were isolated from the aerial parts of Artemisia myriantha. Their structures were elucidated by spectral analyses including UV, IR, HRESIMS, 1D and 2D NMR, ECD and the absolute configurations of compounds 1 and 7–9 were characterized using X-ray crystallography. All isolates were tested their cytotoxicity against three human hepatoma cell lines (HepG2, Huh7, and SK-Hep-1), and compounds 1–3, 7, and 10 showed cytotoxicity with IC₅₀ values ranging from 43.7 to 89.3 μM. Among them, the most active compound 3 exhibited activity against three human hepatoma cell lines with IC₅₀ values of 43.7 μM (HepG2), 47.9 μM (Huh7), and 44.9 μM (SK-Hep-1).

关键词: Artemisia myriantha, Artemyrianosins A–J, Germacrane-type sesquiterpenoids, Cytotoxicity

Xin Zhang, Yun-Bao Ma, Xiao-Feng He, Tian-Ze Li, Chang-An Geng, Li-Hua Su, Shuang Tang, Zhen Gao, Ji-Jun Chen. Artemyrianosins A–J, cytotoxic germacrane-type sesquiterpene lactones from Artemisia myriantha[J]. Natural Products and Bioprospecting, 2022, 12(3): 16-16.

References

1.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mor-tality worldwide for 36 cancers in 185 countries.CA Cancer J Clin.2018;68:394-424.
2.Fattovich G, Strofolini T, Zagni I, Donato F.Hepatocellular carcinoma in cirrhosis:incidence and risk factors.Gastroenterology.2004;127:35-50.
3.Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C, Alsharif U, Alvis-Guzman N, Amini E, Anderson BO, Aremu O, Artaman A, Asgedom SW, Assadi R, Atey TM, Avila-Burgos L, Awasthi A, Ba Saleem HO, Barac A, Bennett JR, Bensenor IM, Bhakta N, Brenner H, Cahuana-Hurtado L, Castaneda-Orjuela CA, Catala-Lopez F, Choi JYJ, Christopher DJ, Chung SC, Curado MP, Dandona L, Dandona R, et al.Global, regional, and national cancer incidence, mortality, years ofife lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016:a systematic analysis for the global burden of disease study.JAMA Oncol.2018;4:1553-68.
4.Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin.2021;71:209-49.
5.Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Len-cioni R, Koike K, ZucmanRossi J, Finn RS.Hepatocellular carcinoma.Nat Rev Dis Primers.2021;7:6.
6.Anwanwan D, Singh SK, Singh S, Saikam V, Singh R.Challenges in liver cancer and possible treatment approaches.Biochim Biophys Acta Rev Cancer.2020;1873:188314.
7.Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J.Sorafenib in advanced hepatocellular carcinoma.N Engl J Med.2008;359:378-90.
8.Dai Q, Zhang C, Yuan Z, Sun Q, Jiang Y.Current discovery strategies for hepatocellular carcinoma therapeutics.Expert Opin Drug Discov.2020;15:243-58.
9.Su L-H, Ma Y-B, Geng C-A, Li T-Z, Huang X-Y, Hu J, Zhang X, Tang S, Shen C, Gao Z, Zhang X-M, Chen J-J.Artematrovirenins A-P, guaiane-type ses-quiterpenoids with cytotoxicities against two hepatoma cell lines from Artemisia atrovirens.Bioorg Chem.2021;114:105072.
10.Tu Y-Y.The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine.Nat Med.2011;17:1217-20.
11.Wang S, Li J, Sun J, Zeng K-W, Cui J-R, Jiang Y, Tu P-F.NO inhibitory guaianolide-derived terpenoids from Artemisia argyi.Fitoterapia.2013;85:169-75.
12.Geng C-A, Huang X-Y, Chen X-L, Ma Y-B, Rong G-Q, Zhao Y, Zhang X-M, Chen J-J.Three new anti-HBV active constituents from the traditional Chinese herb of Yin-Chen (Artemisia scoparia).J Ethnopharmacol.2015;176:109-17.
13.Bora KS, Sharma A.The genus Artemisia:a comprehensive review.Pharm Biol.2011;49:101-9.
14.Wang J, Xu C, Wong Y-K, Li Y-J, Liao F-L, Jiang T-L, Tu Y-Y.Artemisinin, the magic drug discovered from traditional Chinese medicine.Engineering.2019;5:32-9.
15.Yao W, Wang F, Wang H.Immunomodulation of artemisinin and its derivatives.Sci Bull.2016;61:1399-406.
16.Lone SH, Bhat KA, Khuroo MA.Arglabin:from isolation to antitumor evaluation.Chem Biol Interact.2015;240:180-98.
17.Lee SH, Lee MY, Kang HM, Han DC, Son KH, Yang DC, Sung ND, Lee CW, Kim HM, Kwon BM.Anti-tumor activity of the farnesyl-protein transferase inhibitors arteminolides, isolated from Artemisa.Bioorg Med Chem.2003;11:4545-9.
18.Su L-H, Zhang X-T, Ma Y-B, Geng C-A, Huang X-Y, Hu J, Li T-Z, Tang S, Shen C, Gao Z, Zhang X-M, Chen J-J.New guaiane-type sesquiterpenoid dimers from Artemisia atrovirens and their antihepatoma activity.Acta Pharm Sin B.2021;11:1648-66.
19.Su L-H, Li T-Z, Ma Y-B, Geng C-A, Huang X-Y, Zhang X, Gao Z, Chen J-J.Artematrovirenolides A-D and Artematrolides S-Z, Sesquiterpenoid dimers with cytotoxicity against three hepatoma cell lines from Artemisia atrovirens.Chin J Chem.2022;40:104-14.
20.Su L-H, Li T-Z, Geng C-A, Ma Y-B, Huang X-Y, Wang J-P, Zhang X-M, Chen J-J.Trimeric and dimeric sesquiterpenoids from Artemisia atrovirens and their cytotoxicities.Org Chem Front.2021;8:1249-56.
21.Su L-H, Geng C-A, Li T-Z, Ma Y-B, Huang X-Y, Zhang X-M, Chen J-J.Artatro-virenols A and B:Two cagelike sesquiterpenoids from Artemisia atrovirens.J Org Chem.2020;85:13466-71.
22.Zhang X-T, Hu J, Su L-H, Geng C-A, Chen J-J.Artematrolide A inhibited cervical cancer cell proliferation via ROS/ERK/mTOR pathway and meta-bolic shift.Phytomedicine.2021;91:153707.
23.Li T-Z, Yang X-T, Wang J-P, Geng C-A, Ma Y-B, Su L-H, Zhang X-M, Chen J-J.Biomimetic synthesis of lavandiolides H, I, and K and Artematrolide F via diels-alder reaction.Org Lett.2021;23:8380-4.
24.Zan K, Chen X-Q, Zhao M-B, Jiang Y, Tu P-F.Cytotoxic sesquiterpene lactones from Artemisia myriantha.Phytochem Lett.2020;37:33-6.
25.Tang S, Zhang X-T, Ma Y-B, Huang X-Y, Geng C-A, Li T-Z, Zhang X-M, Shen C, Su L-H, Gao Z, Chen J-J.Artemyrianolides A-S, Cytotoxic Sesquiterpe-noids from Artemisia myriantha.J Nat Prod.2020;83:2618-30.
26.Zan K, Chen X-Q, Zhao M-B, Tu P-F.Sesquiterpenoids from aerial parts of Artemisia myriantha.China J Chin Mater Med.2016;41:2833-7.
27.Zan K, Chen X-Q, Tu P-F.Guaianolides from aerial parts of Artemisia myriantha.China J Chin Mater Med.2018;43:2295-9.

[1]	Pengkun Li, Qin Li, Aimin Fu, Yang Xiao, Chunmei Chen, Hucheng Zhu, Changxing Qi, Wei Wei, Yuan Zhou, Yonghui Zhang. Emestrin-type epipolythiodioxopiperazines from Aspergillus nidulans with cytotoxic activities by regulating PI3K/AKT and mitochondrial apoptotic pathways [J]. Natural Products and Bioprospecting, 2025, 15(2): 17-17.
[2]	Dong-Yang Wang, Ming-Xing Li, Yan-Chao Xu, Peng Fu, Wei-Ming Zhu, Li-Ping Wang. Dibohemamines I-O from Streptomyces sp. GZWMJZ-662, an endophytic actinomycete from the medicinal and edible plant Houttuynia cordata Thunb. [J]. Natural Products and Bioprospecting, 2025, 15(1): 9-9.
[3]	Yue-Mei Chen, Nan-Kai Cao, Si-Si Zhu, Meng Ding, Hai-Zhen Liang, Ming-Bo Zhao, Ke-Wu Zeng, Peng-Fei Tu, Yong Jiang. Euchrestifolines A-O, fifteen novel carbazole alkaloids with potent anti-ferroptotic activity from Murraya euchrestifolia [J]. Natural Products and Bioprospecting, 2025, 15(1): 5-5.
[4]	Alica Fischle, Mika Lutsch, Florian Hübner, Linda Sch?ker-Hübner, Lina Schürmann, Finn K. Hansen, Svetlana A. Kalinina. Micro-scale screening of genetically modified Fusarium fujikuroi strain extends the apicidin family [J]. Natural Products and Bioprospecting, 2024, 14(6): 51-51.
[5]	Qi-Xiu Hai, Kun Hu, Su-Ping Chen, Yang-Yang Fu, Xiao-Nian Li, Han-Dong Sun, Hong-Ping He, Pema-Tenzin Puno. Silvaticusins A-D: ent-kaurane diterpenoids and a cyclobutane-containing ent-kaurane dimer from Isodon silvaticus [J]. Natural Products and Bioprospecting, 2024, 14(5): 45-45.
[6]	Shuyuan Mo, Ziming Zhao, Zi Ye, Zhihong Huang, Yaxin Zhang, Wanqi Yang, Jianping Wang, Zhengxi Hu, Yonghui Zhang. New secondary metabolites with cytotoxicity from fungus Penicillium roqueforti [J]. Natural Products and Bioprospecting, 2023, 13(3): 17-17.
[7]	Li Hou, Cui-Xuan Mei, Chun-Mao Yuan, Gui-Hua Tang, Duo-Zhi Chen, Qing Zhao, Hong-Ping He, Ming-Ming Cao, Xiao-Jiang Hao. Five new limonoids isolated from Walsura robusta [J]. Natural Products and Bioprospecting, 2023, 13(2): 7-7.
[8]	Ya-Li Hu, Xing-Ren Li, Gang Xu. Carascynol A, a hybrid of caryophyllane-type terpenoid and a C₆ unit degraded by polyprenylated acylphloroglucinols from Hypericum ascyron [J]. Natural Products and Bioprospecting, 2022, 12(6): 38-38.
[9]	Natividad Herrera Cano, Sebastian A. Andujar, Cristina Theoduloz, Daniel A. Wunderlin, Ana N. Santiago, Guillermo Schmeda-Hirschmann, Ricardo D. Enriz, Gabriela E. Feresin. Arylated analogues of cypronazole: fungicidal effect and activity on human fibroblasts. Docking analysis and molecular dynamics simulations [J]. Natural Products and Bioprospecting, 2022, 12(2): 9-9.
[10]	Ruo-Song Zhang, Yang-Yang Liu, Pei-Feng Zhu, Qiong Jin, Zhi Dai, Xiao-Dong Luo. Furostanol Saponins from Asparagus cochinchinensis and Their Cytotoxicity [J]. Natural Products and Bioprospecting, 2021, 11(6): 651-658.
[11]	Patrick O. Sakyi, Richard K. Amewu, Robert N. O. A. Devine, Emahi Ismaila, Whelton A. Miller, Samuel K. Kwofie. The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade [J]. Natural Products and Bioprospecting, 2021, 11(5): 489-544.
[12]	Chen Shi, Yue-Ling Peng, Juan He, Zheng-Hui Li, Ji-Kai Liu, Tao Feng. Structures, Chemical Conversions, and Cytotoxicity of Tricholopardins C and D, Two Tricholoma Triterpenoids from the Wild Mushroom Tricholoma pardinum [J]. Natural Products and Bioprospecting, 2021, 11(2): 235-241.
[13]	Yi Chen, Song-Wei Li, Fang-Zhou Yin, Min Yang, Xia-Juan Huan, Ze-Hong Miao, Xiao-Ming Wang, Yue-Wei Guo. Lagerindicine, a New Pyrrole Alkaloid Isolated from the Flowers of Lagerstroemia indica Linnaeus [J]. Natural Products and Bioprospecting, 2021, 11(1): 73-79.
[14]	Mohammad Sanad Abu-Darwish, Célia Cabral, Zulfigar Ali, Mei Wang, Shabana I. Khan, Melissa R. Jacob, Surendra K. Jain, Babu L. Tekwani, Fazila Zulfiqar, Ikhlas A. Khan, Hatem Taifour, Lígia Salgueiro, Thomas Efferth. Salvia ceratophylla L. from South of Jordan: new insights on chemical composition and biological activities [J]. Natural Products and Bioprospecting, 2020, 10(5): 307-316.
[15]	Cheng Shen, Xiao-Yan Huang, Chang-An Geng, Tian-Ze Li, Shuang Tang, Li-Hua Su, Zhen Gao, Xue-Mei Zhang, Jing Hu, Ji-Jun Chen. Artemlavanins A and B from Artemisia lavandulaefolia and Their Cytotoxicity Against Hepatic Stellate Cell Line LX2 [J]. Natural Products and Bioprospecting, 2020, 10(4): 243-250.

Artemyrianosins A–J, cytotoxic germacrane-type sesquiterpene lactones from Artemisia myriantha

Artemyrianosins A–J, cytotoxic germacrane-type sesquiterpene lactones from Artemisia myriantha

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments